Incidence of postpartum depression in low-income cannabis users with and without a history of depression.
Postpartum depression
cannabis
depression
pregnancy
Journal
Archives of women's mental health
ISSN: 1435-1102
Titre abrégé: Arch Womens Ment Health
Pays: Austria
ID NLM: 9815663
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
received:
21
07
2023
accepted:
24
10
2023
medline:
1
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
aheadofprint
Résumé
While past research has linked cannabis use in pregnancy with a history of depression, sparse literature exists on cannabis use during pregnancy and postpartum depression (PPD). In this study, we aimed to better understand the association between PPD and cannabis use during pregnancy in those with and without a history of depression. This was a retrospective cohort study of patients who received prenatal care at a single institution between January 2017 and December 2019. Patient demographics, obstetric history, depression history, substance use history, and Edinburgh Postnatal Depression Scale (EPDS) scores were extracted from patients' medical records. Modified Poisson Regression with robust standard errors was used to estimate the relative risk (RR) of screening positive for PPD, adjusting for age at delivery, race/ethnicity, insurance type, marital status, and smoking history. Among the 799 subjects meeting inclusion criteria, 15.9% used cannabis during pregnancy. There was an increased risk of screening positive for PPD among prenatal cannabis users compared to non-users (aRR = 1.60, 95% CI: (1.05, 2.45)). Among individuals with a history of depression, the adjusted relative risk of screening positive for symptoms of PPD at the postpartum visit was 1.62 times greater in cannabis users compared to non-users (95% CI: (1.02, 2.58)). Prenatal cannabis use is associated with screening positive for PPD, particularly in those individuals with a history of depression. These results should discourage women with depression from self-medicating with cannabis in pregnancy and provide additional support to the existing recommendations to abstain from prenatal cannabis use.
Identifiants
pubmed: 37910199
doi: 10.1007/s00737-023-01389-y
pii: 10.1007/s00737-023-01389-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
Agrawal A, Rogers CE, Lessov-Schlaggar CN, Carter EB, Lenze S, Grucza RA (2019) Changes in alcohol, cigarette and cannabis use between 2002 and 2016 in pregnant females from a nationally representative sample. JAMA Pediatr 173(1):95–96. https://doi.org/10.1001/jamapediatrics.2018.3096
doi: 10.1001/jamapediatrics.2018.3096
pubmed: 30398527
American College of Obstetricians and Gynecologists Committee on Obstetric Practice (2017) Committee opinion no. 722: marijuana use during pregnancy and lactation. Obstet Gynecol 130:e205–e209
doi: 10.1097/AOG.0000000000002354
Barbosa-Leiker C, Burduli E, Smith CL, Brooks O, Orr M, Gartstein M (2020) Daily cannabis use during pregnancy and postpartum in a state with legalized recreational cannabis. J Addict Med 14(6):467–474. https://doi.org/10.1097/ADM.0000000000000625
doi: 10.1097/ADM.0000000000000625
pubmed: 32011411
pmcid: 7647431
Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS (2017) Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA 317(2):207–209. https://doi.org/10.1001/jama.2016.17383
doi: 10.1001/jama.2016.17383
pubmed: 27992619
pmcid: 5595220
Cao S, Jones M, Tooth L, Mishra GD (2021) Association between preconception cannabis use and risk of postpartum depression: findings from an Australian longitudinal cohort. Drug Alcohol Depend 226:108860. https://doi.org/10.1016/j.drugalcdep.2021.108860
doi: 10.1016/j.drugalcdep.2021.108860
pubmed: 34198130
Chang JC, Tarr JA, Holland CL et al (2019) Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use. Drug Alcohol Depend 196:14–20. https://doi.org/10.1016/j.drugalcdep.2018.11.028
doi: 10.1016/j.drugalcdep.2018.11.028
pubmed: 30658220
pmcid: 6756431
Corsi DJ, Hsu H, Weiss D, Fell DB, Walker M (2019) Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017. Can J Public Health 110(1):76–84. https://doi.org/10.17269/s41997-018-0148-0
doi: 10.17269/s41997-018-0148-0
pubmed: 30387034
Corsi DJ, Donelle J, Sucha E et al (2020) Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nat Med 26(10):1536–1540. https://doi.org/10.1038/s41591-020-1002-5
doi: 10.1038/s41591-020-1002-5
pubmed: 32778828
Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782–786. https://doi.org/10.1192/bjp.150.6.782
doi: 10.1192/bjp.150.6.782
pubmed: 3651732
Crume TL, Juhl AL, Brooks-Russell A, Hall KE, Wymore E, Borgelt LM (2018) Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr 197:90–96. https://doi.org/10.1016/j.jpeds.2018.02.005
doi: 10.1016/j.jpeds.2018.02.005
pubmed: 29605394
Gnofam M, Allshouse AA, Stickrath EH, Metz TD (2020) Impact of marijuana legalization on prevalence of maternal marijuana use and perinatal outcomes. Am J Perinatol 37(1):59–65. https://doi.org/10.1055/s-0039-1696719
doi: 10.1055/s-0039-1696719
pubmed: 31491805
Goldschmidt L, Richardson GA, Willford J, Day NL (2008) Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry 47(3):254–263. https://doi.org/10.1097/CHI.0b013e318160b3f0
doi: 10.1097/CHI.0b013e318160b3f0
pubmed: 18216735
Goodwin RD, Zhu J, Heisler Z et al (2020) Cannabis use during pregnancy in the United States: the role of depression. Drug Alcohol Depend 210:107881. https://doi.org/10.1016/j.drugalcdep.2020.107881
doi: 10.1016/j.drugalcdep.2020.107881
pubmed: 32143978
Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37–48
doi: 10.1097/00001648-199901000-00008
pubmed: 9888278
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Holland CL, Rubio D, Rodriguez KL et al (2016) Obstetric health care providers’ counseling responses to pregnant patient disclosures of marijuana use. Obstet Gynecol 127(4):681–687. https://doi.org/10.1097/AOG.0000000000001343
doi: 10.1097/AOG.0000000000001343
pubmed: 26959210
pmcid: 4805441
Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM (2015) Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol 213(2):201.e1–201.e10. https://doi.org/10.1016/j.ajog.2015.03.021
doi: 10.1016/j.ajog.2015.03.021
pubmed: 25772211
Ko JY, Tong VT, Bombard JM, Hayes DK, Davy J, Perham-Hester KA (2018) Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: a population-based study. Drug Alcohol Depend 187:72–78. https://doi.org/10.1016/j.drugalcdep.2018.02.01
doi: 10.1016/j.drugalcdep.2018.02.01
pubmed: 29627409
pmcid: 7479809
Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M (2017) Pregnant women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm. J Addict Med 11(3):211–216. https://doi.org/10.1097/ADM.0000000000000299
doi: 10.1097/ADM.0000000000000299
pubmed: 28252456
Odom GC, Cottler LB, Striley CW, Lopez-Quintero C (2020) Perceived risk of weekly cannabis use, past 30-day cannabis use, and frequency of cannabis use among pregnant women in the United States. Int J Women's Health 12:1075–1088. https://doi.org/10.2147/IJWH.S266540
doi: 10.2147/IJWH.S266540
Pike CK, Sofis MJ, Budney AJ (2021) Correlates of continued cannabis use during pregnancy. Drug Alcohol Depend 227:108939. https://doi.org/10.1016/j.drugalcdep.2021.108939
doi: 10.1016/j.drugalcdep.2021.108939
pubmed: 34358772
pmcid: 8464496
R Core Team (2022) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Shorey S, Chee CYI, Ng ED, Chan YH, Tam WWS, Chong YS (2018) Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res 104:235–248. https://doi.org/10.1016/j.jpsychires.2018.08.001
doi: 10.1016/j.jpsychires.2018.08.001
pubmed: 30114665
Silverman ME, Reichenberg A, Savitz DA et al (2017) The risk factors for postpartum depression: a population-based study. Depress Anxiety 34(2):178–187. https://doi.org/10.1002/da.22597
doi: 10.1002/da.22597
pubmed: 28098957
pmcid: 5462547
Skelton KR, Hecht AA, Benjamin-Neelon SE (2020) Recreational cannabis legalization in the US and maternal use during the preconception, prenatal, and postpartum periods. Int J Environ Res Public Health 17(3):909. https://doi.org/10.3390/ijerph17030909
doi: 10.3390/ijerph17030909
pubmed: 32024173
pmcid: 7037220
Volkow ND, Han B, Compton WM, McCance-Katz EF (2019) Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA 322(2):167–169. https://doi.org/10.1001/jama.2019.7982
doi: 10.1001/jama.2019.7982
pubmed: 31211824
pmcid: 6582258
Young-Wolff KC, Sarovar V, Tucker LY et al (2019) Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy. JAMA Netw Open 2(7):e196471. https://doi.org/10.1001/jamanetworkopen.2019.6471
doi: 10.1001/jamanetworkopen.2019.6471
pubmed: 31322686
pmcid: 6646980
Young-Wolff KC, Sarovar V, Tucker LY et al (2020) Association of depression, anxiety, and trauma with cannabis use during pregnancy. JAMA Netw Open 3(2):e1921333. https://doi.org/10.1001/jamanetworkopen.2019.21333
doi: 10.1001/jamanetworkopen.2019.21333
pubmed: 32074285
pmcid: 7098171